entri
sarscov
target
cell
initi
bind
domain
spike
protein
receptor
follow
conform
chang
spike
protein
domain
result
format
sixhelix
bundl
heptadrepeat
region
previou
studi
demonstr
peptid
deriv
region
could
inhibit
sarscov
entri
howev
synthesi
peptid
high
cost
studi
design
two
recombin
protein
one
contain
two
one
peptid
denot
consist
two
one
peptid
design
two
protein
could
easili
purifi
low
cost
product
exhibit
high
stabil
potent
inhibitori
activ
entri
hivsar
pseudovirus
ic
valu
lm
respect
featur
suggest
serv
potent
inhibitor
sarscov
entri
envelop
positivestrand
rna
virus
envelop
glycoprotein
envelop
virus
initi
entri
virus
host
cell
bind
cell
surfac
receptor
follow
conform
chang
lead
membran
fusion
deliveri
genom
cytoplasm
sarscov
fusion
process
mediat
spike
protein
surfac
viru
spike
protein
typic
class
viral
fusion
protein
like
transmembran
glycoprotein
mani
envelop
virus
compos
two
subunit
surfac
subunit
bind
host
cell
surfac
receptor
transmembran
subunit
ultim
insert
host
cell
membran
promot
fusion
event
domain
spike
protein
contain
two
helic
region
one
near
amino
terminu
near
carboxi
terminu
well
conserv
late
stage
membran
fusion
two
region
interact
antiparallel
manner
form
trimerofhairpin
share
signific
similar
fusion
core
structur
mhv
spike
protein
viral
fusion
protein
facilit
juxtaposit
viru
cell
membran
lead
membran
fusion
moreov
peptid
deriv
region
spike
protein
found
inhibitori
activ
retroviru
paramyxoviru
fusion
protein
peptid
like
inhibit
format
trimerofhairpin
dominantneg
manner
bind
region
like
fig
first
inhibitor
approv
us
food
drug
administr
fda
european
commiss
treatment
hiv
infect
adult
children
age
year
older
howev
one
major
limit
difficulti
peptid
synthesi
result
high
cost
product
insuffici
suppli
accordingli
necessari
find
analog
peptid
inhibitor
fusioninhibitori
activ
product
low
cost
recombin
protein
contain
segment
separ
short
hydrophil
sixresidu
linker
produc
shown
fold
thermal
stabl
sixhelix
bundl
also
previous
shown
protein
number
paramyxoviru
f
protein
ndv
mump
viru
measl
viru
menangl
viru
could
also
form
typic
sixhelix
bundl
use
success
crystal
base
previou
construct
design
two
protein
analog
respect
one
hr
sequenc
link
led
format
studi
use
gstfusion
system
express
separ
escherichia
coli
e
coli
could
easili
express
purifi
exhibit
stabl
ahel
structur
solut
potent
inhibitori
activ
entri
hivsar
pseudotyp
viru
plasmid
cell
line
r
hivluc
codon
optim
sarscov
protein
express
plasmid
pctsh
strain
genbank
access
gift
dr
hongkui
deng
util
product
hivsar
pseudovirus
cell
use
pseudotyp
viru
gener
huh
cell
use
prehairpin
intermedi
central
coiledcoil
form
three
three
expos
could
target
exogen
hr
absenc
inhibitor
transient
state
ultim
collaps
sixhelix
bundl
brought
region
close
proxim
promot
membran
fusion
entri
inhibitor
black
cylind
target
region
prevent
format
sixhelix
bundl
b
contain
two
segment
one
segment
altern
link
short
glyser
peptid
sequenc
consist
two
segment
one
segment
sequenc
construct
peptid
respect
linker
ggsgg
linker
sggrgg
c
schemat
model
trimer
left
right
assembl
sixhelix
bundl
free
cellcel
fusion
assay
cultur
modifi
medium
supplement
fetal
bovin
serum
gene
construct
learn
coilvmf
program
use
predict
amino
acid
sequenc
region
gene
encod
amino
acid
amplifi
pcr
pctsh
base
find
select
construct
consist
two
segment
one
segment
altern
link
short
peptid
sequenc
consist
two
segment
one
segment
fig
gene
encod
two
protein
subclon
e
coli
express
vector
two
restrict
enzym
site
ecori
xhoi
stop
codon
introduc
xhoi
site
clone
strategi
yield
glutathion
stransferas
gst
fusion
protein
fusion
protein
name
respect
subclon
bamhixhoi
site
yield
protein
ntermin
histag
thrombin
enterokinas
cleavag
site
purifi
protein
name
respect
protein
express
purif
recombin
plasmid
plasmid
transform
e
coil
strain
singl
coloni
respect
transform
grown
yt
optic
densiti
od
nm
induc
mm
iptg
h
bacteri
cell
harvest
lyse
sonic
phosphatebuff
salin
pb
mm
sodium
phosphat
ph
mm
nacl
triton
ad
final
concentr
lysat
incub
min
ice
subsequ
clarifi
centrifug
min
clarifi
supernat
appli
glutathionesepharos
affin
column
pharmacia
column
wash
bed
volum
pb
elut
reduc
lglutathion
mm
protein
subsequ
cleav
fusion
protein
gstfusion
rhinoviru
proteas
kindli
provid
dr
k
hudson
j
heath
load
glutathionesepharos
affin
column
remov
gst
sampl
purifi
hiload
superdex
column
pharmacia
run
akta
explor
fplc
system
amershampharmacia
fraction
peak
collect
run
sdspage
peak
molecular
weight
estim
comparison
protein
standard
pharmacia
run
column
clarifi
supernat
appli
nichel
sepharos
affin
column
pharmacia
column
wash
pb
column
volum
elut
imidazol
mm
respect
chemic
crosslink
done
accord
method
describ
earlier
briefli
gelfiltr
purifi
dialyz
crosslink
buffer
mm
hepe
ph
mm
nacl
separ
concentr
mgml
ultrafiltr
kda
cutoff
protein
crosslink
ethylen
glycol
bi
succinimidyl
succin
eg
dissolv
dmso
sigma
reaction
incub
h
ice
concentr
mm
eg
stop
mm
glycin
crosslink
product
analyz
reduc
condit
sdspage
cd
spectroscopi
cd
spectra
perform
jasco
spectrophotomet
protein
pb
wavelength
spectra
record
use
cm
pathlength
cuvett
protein
concentr
use
lgml
gst
pulldown
assay
excess
classifi
bacterium
supernat
respect
mix
mixtur
incub
h
room
temperatur
glutathionesepharos
affin
gel
ad
gel
protein
mixtur
incub
gentl
agit
room
temperatur
min
suspens
centrifug
min
sediment
gel
adsorb
fusion
protein
complex
column
wash
bed
volum
pb
elut
reduc
lglutathion
elut
sampl
analyz
sdspage
inhibit
hivsar
pseudoviru
entri
hivsar
pseudoviru
produc
describ
deng
r
pctsh
cotransfect
cell
forti
eight
hour
later
hivsar
pseudoviruscontain
supernat
mix
serial
dilut
protein
virusprotein
mixtur
transfer
plate
seed
huh
cell
three
hour
later
medium
replac
follow
day
incub
cell
harvest
lysi
buffer
analyz
luciferas
activ
addit
luciferas
substrat
measur
luminomet
ic
valu
calcul
fit
titrat
data
langmuir
function
normal
luciferas
activ
cic
trimer
core
ectodomain
sarscov
solv
crystallograph
compris
residu
sarscov
coval
link
linker
structur
form
thermost
trimer
hairpin
entir
helic
arrang
sixhelix
bundl
made
use
core
scaffold
link
anoth
c
terminu
anoth
n
terminu
respect
fig
ration
design
three
stabil
consequ
coval
link
ectodomain
core
flexibl
linker
stabil
design
improv
studi
produc
use
recombin
e
coli
express
system
abl
provid
protein
product
larg
quantiti
low
cost
design
two
protein
express
gst
fusion
protein
solubl
form
easi
elut
glutathionesepharos
column
normal
elut
buffer
mm
reduc
glutathion
mm
trishcl
ph
moreov
two
gst
fusion
protein
could
easili
cleav
proteas
fig
name
free
easili
express
purifi
larg
quantiti
low
cost
purifi
analyz
gel
filtrat
estim
molecular
weight
assembl
charact
elut
peak
protein
peak
posit
correspond
kda
calcul
molecular
weight
kda
respect
indic
could
form
oligom
probabl
trimer
fig
b
subsequ
chemic
crosslink
demonstr
could
inde
form
trimer
fig
although
monomerdim
band
complet
disappear
even
high
concentr
crosslink
howev
densiti
trimer
band
tend
get
thicker
gradual
increas
crosslink
concentr
molecular
weight
crosslink
trimer
around
kda
close
theoret
valu
gave
strong
evid
could
still
assembl
sixhelix
bundl
structur
pb
similar
form
howev
sixhelix
bundl
form
also
three
superflu
differ
form
biophys
properti
individu
protein
concern
test
cd
spectrometri
describ
materi
method
cd
spectrum
exhibit
doubl
minima
nm
unord
indic
show
salient
ahelix
charact
fig
b
name
two
protein
stabl
singl
could
bind
vitro
could
pull
bound
bind
bound
pull
fig
moreov
could
pull
data
shown
impli
gst
well
fusion
partner
extra
amino
acid
affect
bind
activ
ellipt
nm
increas
upon
mix
also
increas
upon
mix
fig
b
increas
ellipt
nm
upon
mix
indic
interact
two
protein
interact
induc
helic
conform
result
show
analog
monom
could
bind
analog
studi
strong
tendenc
aggreg
partial
solubl
liabl
precipit
pb
solubl
clarifi
bacterium
supernat
solubl
pb
supernat
aggreg
high
concentr
hand
peptid
bound
region
spike
protein
accord
crystal
structur
could
pull
data
shown
due
two
reason
analyz
spectra
mixtur
mixtur
cd
spectra
analysi
howev
solubl
pb
aggreg
even
high
concentr
say
stabl
respect
analog
could
inhibit
hivsar
pseudoviru
mediat
cell
fusion
sarscov
forbidden
use
experiment
materi
govern
hivsar
pseudoviru
use
cell
fusion
assay
safe
conform
mimet
sarscov
exhibit
antivir
activ
fig
ic
valu
lm
respect
construct
previou
studi
also
test
inhibitori
activ
hivsar
pseudoviru
ic
valu
lm
approxim
howev
effect
viru
infect
analog
fusion
inhibitori
activ
propos
format
bundl
fig
irrevers
physiolog
condit
could
revers
physiolog
condit
expos
segment
expos
bound
viral
region
prevent
format
sixhelix
bundl
therebi
block
fusion
mechan
individu
peptid
take
consider
design
protein
inhibit
entri
hivsar
pseudoviru
inhibitori
activ
compar
moreov
design
protein
easili
purifi
low
cost
product
stabl
singl
accordingli
design
strategi
also
use
envelop
virus
especi
hiv
